Listen to article
The United States is recommending a ‘pause’ in the administration of the Johnson & Johnson COVID-19 vaccine to investigate reports of blood clots which has been reported severally in the country.
The U.S. made this recommendation to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, made available to the press yesterday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts.
According to reports, the U.S. has administered over 6.8 million doses of the J&J vaccine so far.
U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow.
CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.
‘Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,’ Dr. Anne Schuchat, Principal Deputy Director of the CDC, and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.
AFRICA TODAY NEWS, NEW YORK